Global Blood Glucose Monitoring (BGM) Market Growth 2023-2029
Continuous Glucose Monitoring is an advanced way for people living with diabetes to check glucose readings in real-time or monitor glucose readings over a period of time.
LPI (LP Information)' newest research report, the “Blood Glucose Monitoring (BGM) Industry Forecast” looks at past sales and reviews total world Blood Glucose Monitoring (BGM) sales in 2022, providing a comprehensive analysis by region and market sector of projected Blood Glucose Monitoring (BGM) sales for 2023 through 2029. With Blood Glucose Monitoring (BGM) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Glucose Monitoring (BGM) industry.
This Insight Report provides a comprehensive analysis of the global Blood Glucose Monitoring (BGM) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Glucose Monitoring (BGM) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Blood Glucose Monitoring (BGM) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Glucose Monitoring (BGM) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Glucose Monitoring (BGM).
The global Blood Glucose Monitoring (BGM) market size is projected to grow from US$ 7696.2 million in 2022 to US$ 10640 million in 2029; it is expected to grow at a CAGR of 10640 from 2023 to 2029.
The U.S. market is projected to dominate the strip test segment due to the rise in the patient population, innovation in technology and health care spending while China has the highest number of self-monitoring system users. Asia Pacific and Europe are anticipated to grow over the forecast period owing to increase in some diabetic patients, lifestyle changes, increasing the prevalence of diabetes, and increasing research on diabetes and continuous innovation in technologies and its management. China is expected to witness significant growth for the BRIC diabetes device market followed by other countries such as India, Russia and Brazil.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Glucose Monitoring (BGM) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Blood Glucose Meters
Continuous Glucose Monitoring Devices
Lancets
Blood Glucose Testing Strips
Segmentation by application
Hospital Use
Clinic Use
Household
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Becton
Dickinson and Co.
Terumo Corporation
Acon Laboratories Inc.
Roche Diagnostics Ltd.
Johnson & Johnson
ARKRAY Inc.
Novo Nordisk A/S
Medtronic
Abbott Laboratories
Bayer AG
Ypsomed AG
Sanofi
Key Questions Addressed in this Report
What is the 10-year outlook for the global Blood Glucose Monitoring (BGM) market?
What factors are driving Blood Glucose Monitoring (BGM) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Blood Glucose Monitoring (BGM) market opportunities vary by end market size?
How does Blood Glucose Monitoring (BGM) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.